Abstract
Nanotechnology is a cutting edge and rapidly evolving technology in medicine. The potential of nanomedicine in cancer therapy is infinitely promising due to the fact that novel developments are constantly being explored. This is particularly the case in the use of nanoparticles in both tumor diagnosis, as well as treatment. This article will attempt to describe some recent advances using nanoparticle drug delivery system in cancer therapy. The evolution history, the challenges and the role of nanoparticles in cancer drug delivery will briefly be discussed together with additional opportunities in cancer therapy. An overall understanding of these issues will help with further advancement of designing better drug delivery system that can be applied clinically.
Keywords: Nanotechnology, drug delivery, tumor therapy, EVOLUTION OF NANOMEDICINE, CANCER DRUG THERAPY, Blood Brain Barrier (BBB), Tumor Barrier, Systemic Toxicity, Basic Nano Systems, Gold Nanoparticles
Current Drug Delivery
Title: Nanomedicine: A New Frontier in Cancer Therapeutics
Volume: 8 Issue: 3
Author(s): Pui Yan Lee and Kenneth K.Y. Wong
Affiliation:
Keywords: Nanotechnology, drug delivery, tumor therapy, EVOLUTION OF NANOMEDICINE, CANCER DRUG THERAPY, Blood Brain Barrier (BBB), Tumor Barrier, Systemic Toxicity, Basic Nano Systems, Gold Nanoparticles
Abstract: Nanotechnology is a cutting edge and rapidly evolving technology in medicine. The potential of nanomedicine in cancer therapy is infinitely promising due to the fact that novel developments are constantly being explored. This is particularly the case in the use of nanoparticles in both tumor diagnosis, as well as treatment. This article will attempt to describe some recent advances using nanoparticle drug delivery system in cancer therapy. The evolution history, the challenges and the role of nanoparticles in cancer drug delivery will briefly be discussed together with additional opportunities in cancer therapy. An overall understanding of these issues will help with further advancement of designing better drug delivery system that can be applied clinically.
Export Options
About this article
Cite this article as:
Yan Lee Pui and K.Y. Wong Kenneth, Nanomedicine: A New Frontier in Cancer Therapeutics, Current Drug Delivery 2011; 8 (3) . https://dx.doi.org/10.2174/156720111795256110
DOI https://dx.doi.org/10.2174/156720111795256110 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Application of Serial Analysis of Gene Expression in Cancer Research
Current Pharmaceutical Biotechnology Asbestos-Related Diseases: Still a Concern in Emerging Economies in the Absence of an International Ban
Current Respiratory Medicine Reviews Flavonoid-Based Cancer Therapy: An Updated Review
Anti-Cancer Agents in Medicinal Chemistry Towards Human on a Chip: Recent Progress and Future Perspective
Micro and Nanosystems Novel Drug-Induced Pulmonary Complications in Cancer Patients You Can Save Life!
Current Respiratory Medicine Reviews Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics
Current Drug Metabolism Metallodrugs in Targeted Cancer Therapeutics: Aiming at Chemoresistance- related Patterns and Immunosuppressive Tumor Networks
Current Medicinal Chemistry Melanoma
Current Cancer Therapy Reviews Utilising Nanotechnology and Nanosystems for Treatment of Rare Diseases
Pharmaceutical Nanotechnology Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments
Current Medicinal Chemistry Intraperitoneal Oncolytic and Tumor Vaccination Therapy with Replication-Competent Recombinant Virus: The Herpes Paradigm
Current Gene Therapy Adenovirus-based Immunotherapy for Prostate Cancer
Current Cancer Therapy Reviews Pulmonary Surfactant Proteins A and D: Innate Immune Functions and Biomarkers for Lung Diseases
Current Pharmaceutical Design miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke
MicroRNA Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy Tip60: Main Functions and Its Inhibitors
Mini-Reviews in Medicinal Chemistry Patent Analysis as a Tool for Research Planning: Study on Natural Based Therapeutics Against Cancer Stem Cells
Recent Patents on Anti-Cancer Drug Discovery Current Targeting Strategies for Adenovirus Vectors in Cancer Gene Therapy
Current Cancer Drug Targets Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of Cancer
Current Drug Targets New Developments in the Management of Pleural Effusions
Current Respiratory Medicine Reviews